Company page

Cytomx Therapeutics, Inc.

Cytomx Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker CTMX. The company focuses on developing innovative cancer therapies using its proprietary Probody platform. As of now, Cytomx has a market capitalization of approximately $788 million.